Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoPA-D: Albumin in Decompensated Cirrhosis
NCT05937048Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2023
- Primary completion
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in decompensated cirrhosis comparing Albumin with Standard of Care (2 arms). Primary endpoint: Change in ROTEM based coagulation parameters at 3 days. Started Jul 2023; status: completed.
02
Drugs
albumin (human)
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT05937048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05937048.